scholarly journals A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis

Nephron ◽  
2020 ◽  
Vol 144 (8) ◽  
pp. 372-382 ◽  
Author(s):  
Tadao Akizawa ◽  
Yusuke Yamaguchi ◽  
Tetsuro Otsuka ◽  
Michael Reusch
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Study ◽  
Label Study ◽  
Oral Dosing

The evaluation of denosumab safety in patients with chronic kidney disease: An open-label study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e20649-e20649
Author(s):  
Geoffrey Block ◽  
Ogo Egbuna ◽  
Steven Zeig ◽  
Pablo E. Pergola ◽  
Bhupinder Singh ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease

2011 ◽  
Vol 24 (6) ◽  
pp. 756-763 ◽  
Author(s):  
Yasuhiko Tomino ◽  
Yoshio Shimizu ◽  
Chieko Hamada ◽  
Atsushi Kurusu ◽  
Isao Ohsawa ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Elderly Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Antiproteinuric Effect ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document